Moleculin Biotech Inc. (MBRX)
NASDAQ: MBRX
· Real-Time Price · USD
0.67
0.02 (3.43%)
At close: Aug 15, 2025, 3:59 PM
0.69
2.85%
After-hours: Aug 15, 2025, 07:43 PM EDT
Moleculin Biotech Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | 126K | n/a | n/a | n/a | 406K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 29K | 31K | n/a | 31K | 31K | 32K | 35K | 32K | 31K | 140K | 28K | 44K | 34K | 122K | 34K | 34K | 40K | 157K |
Gross Profit | -29K | -31K | 63K | -31K | -31K | -32K | -35K | -32K | -31K | -140K | -28K | -44K | -34K | -122K | -34K | -34K | -40K | -157K |
Operating Income | -5.72M | -5.94M | -6.64M | -7.13M | -6.18M | -6.68M | -8.92M | -5.95M | -6.41M | -8.35M | -7.05M | -9.08M | -7.43M | -7.07M | -5.21M | -6.16M | -5.52M | -6.09M |
Interest Income | 26K | 30K | 47K | 102K | 159K | 241K | 262K | 324K | 390K | 392K | 207K | 33K | 39K | 42K | 70K | 87K | 92K | 57K |
Pretax Income | -7.64M | -6.44M | -1.88M | -10.59M | -4.32M | -4.97M | -10.27M | -5.61M | -5.98M | -7.92M | -6.77M | -8.61M | -6.78M | -6.87M | -2.83M | -4.38M | -4.24M | -4.45M |
Net Income | -7.64M | -6.44M | -1.88M | -10.59M | -4.32M | -4.97M | -10.27M | -5.61M | -5.98M | -7.41M | -5.63M | -8.58M | -6.78M | -6.66M | -2.83M | -4.38M | -4.24M | -4.45M |
Selling & General & Admin | 2.09M | 2.48M | 2.16M | 2.17M | 2.06M | 2.39M | 2.25M | 2.63M | 2.52M | 2.67M | 2.84M | 3.09M | 3.2M | 2.42M | 1.99M | 2.02M | 2.43M | 1.94M |
Research & Development | 3.6M | 3.44M | 4.46M | 4.93M | 4.09M | 4.25M | 6.63M | 3.28M | 3.89M | 5.69M | 4.18M | 5.96M | 4.2M | 4.62M | 3.18M | 4.09M | 3.04M | 4.11M |
Other Expenses | n/a | 31K | 31K | 31K | 31K | 32K | n/a | 32K | 9K | 8K | 32K | 32K | 15K | 32K | 10K | 13K | 8K | 9K |
Operating Expenses | 5.69M | 5.94M | 6.64M | 7.13M | 6.18M | 6.68M | 8.88M | 5.95M | 6.41M | 8.35M | 7.05M | 9.08M | 7.43M | 7.07M | 5.21M | 6.16M | 5.52M | 6.09M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 5.72M | 5.94M | 6.64M | 7.13M | 6.18M | 6.68M | 8.92M | 5.95M | 6.41M | 8.35M | 7.05M | 9.08M | 7.43M | 7.07M | 5.21M | 6.16M | 5.52M | 6.09M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -508K | -1.14M | -33K | n/a | -207K | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 15.53M | 93.44K | 3.38M | 3.71M | 2.54M | 2.47M | 2M | 1.99M | 1.98M | 1.92M | 1.91M | 1.91M | 1.91M | 1.91M | 1.91M | 1.9M | 1.9M | 1.45M |
Shares Outstanding (Diluted) | 15.53M | 93.44K | 3.38M | 3.71M | 2.54M | 2.47M | 2M | 1.99M | 1.98M | 1.92M | 1.91M | 1.91M | 1.91M | 1.91M | 1.91M | 1.9M | 1.9M | 1.45M |
EPS (Basic) | -0.49 | -68.88 | -0.56 | -2.85 | -1.7 | -2.02 | -5.13 | -2.82 | -3.02 | -3.86 | -2.95 | -4.49 | -3.56 | -3.5 | -1.48 | -2.3 | -2.24 | -3.06 |
EPS (Diluted) | -0.49 | -68.88 | -0.56 | -2.85 | -1.7 | -2.02 | -5.13 | -2.82 | -3.02 | -3.86 | -2.95 | -4.49 | -3.56 | -3.5 | -1.48 | -2.3 | -2.24 | -3.06 |
EBITDA | -7.61M | -5.91M | -6.61M | -7.1M | -6.15M | -6.64M | -8.88M | -5.92M | -6.38M | -8.32M | -7.17M | -9.05M | -7.4M | -7.04M | -5.17M | -6.12M | -5.47M | -6.04M |
EBIT | -7.64M | -5.94M | -6.64M | -7.13M | -6.18M | -6.68M | -8.92M | -5.95M | -6.41M | -8.35M | -7.05M | -9.08M | -7.43M | -7.07M | -5.21M | -6.16M | -5.52M | -6.09M |
Depreciation & Amortization | 29K | 31K | 31K | 32K | 31K | 32K | 35K | 32K | 31K | 140K | 28K | 44K | 34K | 122K | 34K | 34K | 40K | 157K |